It's official: we have completed our seed financing round amounting to €1.3 million. The funding is led by the Investitionsbank Berlin (IBB), with the High-Tech Gründerfonds (HTGF) also climbing on board alongside business angel Till Knorr. We look forward to working closely with our partners as we continue to grow and succeed! Check-out the press release here: https://high-tech-gruenderfonds.de/en/chemistry-for-healthcare-start-up-secures-seed-investment-from-investitionsbank-berlin-ibb-and-high-tech-grunderfonds-htgf/
This year has started just fabolous: selected one of the 150 most innovative companies in East Germany (Wirtschaft+Markt, print, 01/2019) and placed among the top 50 start-ups in Germany (fuer-gruender.de, "Studie 2019"). It's great to receive such an appreciation for the things we do and fight for. Of course, we have also been busy promoting our products: we presented the PEC-technology at the Handelsblatt Jahrestagung Pharma 2019 and the Biobilanz 2019 in Berlin. Where to meet us next? We fixed our participation at the 6th Annual Peptide Congress (London) in April including a talk presenting the latest novelties in catch & release peptide purification (https://www.oxfordglobal.co.uk/peptides-congress/). On top we'll be attending the German Peptide Symposium (Cologne) in March. So, we hold the tension and push peptides to the next level with unflinching courage.
Belyntic will be present with a booth at the PEM 2018 in Berlin from November 8 - 10 (https://www.bcp.fu-berlin.de/en/chemie/chemie/forschung/pem8/index.html). A great international selection of scientists will show their contribution to peptide engineering - and Belyntic has some promising stories to tell. Dominik Sarma will stand the ground. Meanwhile, Oliver Reimann will be attending the EuroPEPTIDES in Amsterdam from November 6 - 9 (https://lifesciences.knect365.com/europeptides/). We are very much looking forward to this great allocation of academia and industry to meet and push peptide therapeutics forward. It's all about peptides and we are keen to meet you there. Please get in touch for meeting inquiries.
A milestone for Belyntic is just ahead. We will be attending the 35th European Peptide Symposium (EPS) this year, presenting our technology and product offer. We are truly delighted to be part of this groundbreaking event with leading scientists from all over the world in the field of peptide science. Don't miss our talk, which will be held by Robert Zitterbart, co-founder and inventor of the technology. It will start Tuesday at 4.15 pm. We are also very happy to set up our first corporate booth (no. 206, second floor) in Belyntic's favorite colors, showing our products and creating the space for exchange. Get ready to re-think peptide purification. Be part of our journey and meet us at the EPS 2018!
On July 4th, we happily received the 1st prize for the 3rd phase at BPW Plan in the great building of the Investitionsbank Berlin. It was a real honor to press thumbs next to all the great start-ups. Of course, we were happy that our story about peptides made it to the top. Check: https://www.youtube.com/watch?v=IuptZVQmPUY and watch our application video.
Being elected among the eight finalists for the Achema Gründerpreis, Belyntic will attend this year's Achema World Forum in Frankfurt. We are happy to welcome you at hall 9.2, booth C84 at our exhibition space, next to seven other great start-ups and finalists. Get an impression of our company, technology and product offer. It's all about HPLC-free peptide purification. Please get in contact if you wish a separate meeting slot. We are moreover looking forward to two special action points during the forum: the Gründerpreis award ceremony on Monday at 11 am in the congress center Messe Frankfurt (CMF), (hall "Harmonie") and the pitching session on Tuesday in the Discussion Corner in hall 9.2. Dominik will present Belyntic and its novel technology at 3.20 pm. See you in Frankfurt!
Oliver and Andreas are attending the Dutch Peptide Symposium 2018. On the one-day event in Maastricht on June 5th, Oliver will also introduce Belyntic’s technology in his oral presentation “Enabling parallel and scalable peptide purification by a novel traceless purification linker”. If you are also attending, get in contact with Oliver and Andreas to learn more about possible applications.
On April 26, Belyntic was awarded with the 1st place at 2018’s BPW Plan 2nd phase. Dominik, Robert and Oliver were honored to receive the prize at a well-attended, interactive event in best atmosphere at Admiralspalast Studio in the heart of Berlin. Our thanks go out to the BPW team for well-organized preparation sessions and a nice final event.
Belyntic has applied for the Achema Gründerpreis and BPW Plan 2nd phase. We are happy to announce that we were nominated under top applications in both contests. Andi did great, pitching our technology and business model. Let's see if we can get on the podium - more at the BPW award on 26th April in Berlin and the Achema fair on 11th June in Frankfurt.
Robert (CEO/Head of R&O) will visit the 5th Annual Peptides Congress in London, sharing our idea of personalized medicine and parallel GMP-grade peptide synthesis and purification. Contact firstname.lastname@example.org if you are interested in an appointment on site.